ロード中...
Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancer
The present study was conducted to evaluate the efficacy and safety of a combination regimen of capecitabine plus irinotecan in patients with advanced gastric cancer. Patients with previously untreated metastatic or recurrent, measurable gastric cancer received oral capecitabine 1000 mg m(−2) twice...
保存先:
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361294/ https://ncbi.nlm.nih.gov/pubmed/16641916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603093 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|